Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: what's new 12 months later?
CONCLUSIONS: Disruption of routine healthcare services because of the pandemic translated to reduced 1 year overall and disease-free survival among patients affected by HCC, in the metropolitan area of Paris, France.PMID:37468096 | DOI:10.1016/j.aohep.2023.101141
Source: Annals of Hepatology - Category: Gastroenterology Authors: Raffaele Brustia Mohamed Bouattour Manon Allaire Marie Lequoy Cl émence Hollande H élène Regnault Lorraine Blaise Nathalie Ganne-Carri é Val érie Vilgrain Edouard Larrey Chetana Lim Olivier Scatton Sanaa El Mouhadi Violaine Ozenne Fran çois Paye Pie Source Type: research
More News: Academia | Cancer & Oncology | Carcinoma | COVID-19 | France Health | Gastroenterology | Hepatocellular Carcinoma | Liver Cancer | Men | Pandemics | Study